PEOPLE - Endovasc (US) makes appointment:
This article was originally published in Clinica
Endovasc (Montgomery, Texas), a biotechnology company focusing on cardiovascular disease, has appointed Alan Garber to its scientific advisory board. Dr Garber currently serves as both Professor of medicine, biochemistry, molecular and cellular biology at Bayor College of Medicine and chief of endocrinology, diabetes and metabolism at the Methodist Hospital, Houston, Texas.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.